D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.27% |
| 2 | Healthcare | 11.28% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.03% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSRA
451
DELISTED
CSRA Inc.
CSRA
| $34.3M | 0.05% |
1,147,331
-330,723
| -22% | -$10M |
|
|
MRSH
452
Marsh
MRSH
$86.3B
| $34.2M | 0.05% |
420,323
-95,901
| -19% | -$7.97M |
|
453
Edwards Lifesciences
EW
$47.6B
| $34M | 0.05% |
905,007
+176,835
| +24% | +$6.49M |
|
454
Carter's
CRI
$1.43B
| $33.9M | 0.05% |
288,702
-77,812
| -21% | -$8.06M |
|
455
MSC Industrial Direct
MSM
$7.02B
| $33.9M | 0.05% |
350,790
-147,991
| -30% | -$12.4M |
|
456
AerCap
AER
$23.9B
| $33.9M | 0.05% |
643,874
+185,107
| +40% | +$9.64M |
|
457
PUT
Trip.com Group
TCOM
$27.5B
| $33.6M | 0.05% |
762,800
+559,400
| +275% | +$26.7M |
|
|
ANTX
458
DELISTED
Anthem, Inc.
ANTX
| $33.6M | 0.05% |
+600,000
| New | +$32.6M |
|
|
AMED
459
DELISTED
Amedisys
AMED
| $33.6M | 0.05% |
637,517
+134,151
| +27% | +$7.07M |
|
|
TMX
460
DELISTED
Terminix Global Holdings, Inc.
TMX
| $33.6M | 0.05% |
977,339
+694,916
| +246% | +$22.4M |
|
461
PUT
Bausch Health
BHC
$1.65B
| $33.4M | 0.05% |
1,608,900
-153,200
| -9% | -$2.43M |
|
462
CMS Energy
CMS
$23.1B
| $33.3M | 0.05% |
704,869
+445,690
| +172% | +$21.6M |
|
463
CALL
FedEx
FDX
$74.5B
| $33.3M | 0.05% |
133,600
-66,400
| -33% | -$15.2M |
|
464
Commault Systems
CVLT
$5.89B
| $33.3M | 0.05% |
634,519
+111,823
| +21% | +$6.19M |
|
465
Ecolab
ECL
$75.6B
| $33.3M | 0.05% |
248,018
-3,708
| -1% | -$493K |
|
466
Pentair
PNR
$10.2B
| $33.2M | 0.05% |
700,061
+636,120
| +995% | +$29.7M |
|
467
Norfolk Southern
NSC
$78.8B
| $33.1M | 0.05% |
228,356
+175,954
| +336% | +$23.6M |
|
468
Baxter International
BAX
$11.6B
| $32.9M | 0.05% |
509,439
+215,508
| +73% | +$13.8M |
|
469
Newell Brands
NWL
$2.16B
| $32.9M | 0.05% |
1,063,937
+1,052,944
| +9,578% | +$36.3M |
|
|
BNY
470
Bank of New York Mellon
BNY
$108B
| $32.7M | 0.05% |
607,662
+282,574
| +87% | +$15.1M |
|
471
Brunswick
BC
$5.19B
| $32.5M | 0.04% |
588,675
-60,035
| -9% | -$3.27M |
|
472
Bio-Rad Laboratories Class A
BIO
$8.42B
| $32.5M | 0.04% |
136,202
+124,666
| +1,081% | +$30.2M |
|
473
Coca-Cola
KO
$354B
| $32.5M | 0.04% |
707,358
-1,568,709
| -69% | -$72.1M |
|
474
Entergy
ETR
$54.1B
| $32.2M | 0.04% |
791,104
-265,984
| -25% | -$11.1M |
|
475
TE Connectivity
TEL
$58.8B
| $32.2M | 0.04% |
338,729
-163,016
| -32% | -$15M |
|
Similar funds
D.E. Shaw & Co's Q4 2017 Portfolio in Review
As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.